Lili Qiao

1.1k citations
51 papers · 812 indexed · h-index 17
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Cancer Cells and Metastasis (5 papers)Lung Cancer Treatments and Mutations (5 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Lili Qiao

48 papers receiving 803 citations

Peers

Lili Qiao
Comparison fields: 5 of 110
  • Molecular Biology 314
  • Oncology 196
  • Cancer Research 164
  • Pulmonary and Respiratory Medicine 139
  • Immunology 122
Replace David A. Schoenfeld with:
David A. Schoenfeld United States
Ming Shi China
Yuka Suzuki Japan
Yawen Xu China
Xiaoyin Zhao China
Shun Li China
Rosaria Giordano Italy
Na Song China
Hsi‐Chin Wu Taiwan
Jianfeng Wang China
Lili Qiao relative to David A. Schoenfeld United States David A. Schoenfeld's profile →
Citations per field
00.5×1.5×1.9×
David A. Schoenfeld · 1×
Citations per year

Countries citing papers authored by Lili Qiao

Since Specialization
Citations

This map shows the geographic impact of Lili Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Qiao more than expected).

Fields of papers citing papers by Lili Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Qiao. The network helps show where Lili Qiao may publish in the future.

Co-authorship network of co-authors of Lili Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Qiao. A scholar is included among the top collaborators of Lili Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Qiao. Lili Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 9
4 6
5 2
6 3
7 6
8 24
9 2
10 2
11 5
12 5
13 93
14 1
15 6
16 28
17 10
18 6
19 28
20
[Study on the levels of the bisphenol A, octylphenol, 4-nonylphenol in serum of precocious girls].
20

About Lili Qiao

Lili Qiao is a scholar working on Oncology, Gastroenterology and Developmental Neuroscience, having authored 51 papers that have together received 812 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Cancer Research (164 citations), Oncology (196 citations) and Immunology (122 citations). Lili Qiao has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Ning Liang, Jiandong Zhang, Jian Xie, Guodong Deng, Fengjun Liu, Deguo Xu, Hui Luo, Xinshuang Yu, Yuan Tian and Jingxin Zhang. Their work appears in journals such as Journal of Cleaner Production, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026